The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Oncolytics Biotech, Inc (NASDAQ: ONCY) closed at $1.02 up 0.99% from its previous closing price of $1.01. In other words, the price has increased by $0.99 from its previous closing price. On the day, 0.5 million shares were traded. ONCY stock price reached its highest trading level at $1.04 during the session, while it also had its lowest trading level at $0.97.
Ratios:
For a deeper understanding of Oncolytics Biotech, Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.88 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Lake Street on August 13, 2025, initiated with a Buy rating and assigned the stock a target price of $7.
On October 06, 2022, Maxim Group started tracking the stock assigning a Buy rating and target price of $3.
On February 17, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.H.C. Wainwright initiated its Buy rating on February 17, 2021, with a $15 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ONCY now has a Market Capitalization of 106612136 and an Enterprise Value of 88630336.
Stock Price History:
The Beta on a monthly basis for ONCY is 0.90, which has changed by -0.055555582 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, ONCY has reached a high of $1.51, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is -16.73%, while the 200-Day Moving Average is calculated to be 20.18%.
Shares Statistics:
For the past three months, ONCY has traded an average of 1.05M shares per day and 1140880 over the past ten days. A total of 100.36M shares are outstanding, with a floating share count of 98.09M. Insiders hold about 2.27% of the company’s shares, while institutions hold 9.58% stake in the company. Shares short for ONCY as of 1760486400 were 3210176 with a Short Ratio of 3.06, compared to 1757894400 on 2615949. Therefore, it implies a Short% of Shares Outstanding of 3210176 and a Short% of Float of 3.2800000000000002.
Earnings Estimates
The dynamic stock of Oncolytics Biotech, Inc (ONCY) is currently being evaluated by a team of 4.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.27 and -$0.3 for the fiscal current year, implying an average EPS of -$0.28. EPS for the following year is -$0.33, with 4.0 analysts recommending between -$0.27 and -$0.39.
